Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Paul McAndrew [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Mr. Paul McAndrew, the Company’s Chief Executive Officer, adopted a written trading plan on May 11, 2026. The trading plan begins on August 10, 2026, and ends on June 1, 2027. The trading plan is intended to satisfy the affirmative defense conditions of the Exchange Act Rule 10b5-1(c) and permits Mr. McAndrew to sell up to 40,000 shares of the Company, subject to certain conditions.
|
| Name | Paul McAndrew |
| Title | Chief Executive Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 11, 2026 |
| Expiration Date | June 1, 2027 |
| Arrangement Duration | 295 days |
| Aggregate Available | 40,000 |
| Christine Ortiz [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | Dr. Christine Ortiz, a Member of the Board of Directors, adopted a written trading plan on June 1, 2026. The trading plan begins on August 31, 2026 and ends on February 26, 2027. The trading plan is intended to satisfy the affirmative defense conditions of the Exchange Act Rule 10b5-1(c) and permits Dr. Ortiz to sell up to 15,548 shares of the Company, subject to certain conditions.
|
| Name | Christine Ortiz |
| Title | Member of the Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 1, 2026 |
| Expiration Date | February 26, 2027 |
| Arrangement Duration | 179 days |
| Aggregate Available | 15,548 |